Beyond FDA: The DOJ’s Expanding Role in Health Product Enforcement 03 Nov 2025 Autumn PiccoloCredit: Florida Healthcare Law Firm, Key Vendor A quiet reorganization at DOJ could have ripple effects across emerging health markets....
Unique Issues for Licensed Clinicians Prescribing Compounded Peptides 03 Nov 2025 Autumn PiccoloCredit: Florida Healthcare Law Firm, Key Vendor The use of compounded peptides, particularly GLPs (glucagon-like peptides), presents a complex and...
Kentucky’s Conflicting Signals on Compounded GLP-1s 03 Nov 2025 Autumn PiccoloCredit: Florida Healthcare Law Firm, Key Vendor The Kentucky Board of Nursing (BON) has issued sweeping guidance that APRNs must...
FDA’s Expanding Focus: From RUO Platforms to Mainstream Oversight 03 Nov 2025 Autumn PiccoloCredit: Florida Healthcare Law Firm, Key VendorFDA’s “Green List” for GLP-1 Ingredients On September 5, 2025, the U.S. Food and...